The EU legislature has finally reached an agreement on the text of the Corporate Sustainability Due Diligence Directive (CS3D) (see here our previous client alert). The CS3D profoundly affects the ways companies active in...more
On October 16, 2023, the Committee on International Trade (INTA) and the Committee on Internal Market and Consumer Protection (IMCO) of the European Parliament adopted their position (the Committee Position; see here and...more
On 23 February 2022, the European Commission (“Commission”) adopted a proposal for a Corporate Sustainability Due Diligence Directive (“Proposed Directive”) laying down new obligations for large companies to ensure that their...more
The year 2021 was a prolific one for environmental, social and governance (ESG) in the EU. The year 2022 looks just as productive for the EU legislature....more
On 9 December 2021, the European Commission’s (“Commission”) EU Taxonomy Climate Change Delegated Act (“DA”) was published in the Official Journal of the EU after being approved by the European Council. It will enter into...more
The past two weeks have seen two major developments in relation to the screening of foreign direct investment in the European Union (“EU”) for national security or public order reasons. First, on December 10, 2018, the EU...more
12/21/2018
/ Acquisitions ,
CFIUS ,
China ,
Critical Infrastructure Sectors ,
EU ,
European Commission ,
Export Controls ,
Foreign Direct Investment ,
Foreign Investment ,
France ,
Germany ,
INTA ,
Italy ,
Member State ,
Mergers ,
National Security ,
Proposed Regulation ,
Screening Procedures ,
Trade Relations ,
Treaty of Lisbon
This is the fifth issue of WilmerHale’s 8-in-8 Recent Trends in European Law and Policy Alert Series. Our attorneys will share insights on current and emerging issues affecting companies doing business in Europe and across...more
6/25/2018
/ EU ,
Free Trade Agreements ,
GDP ,
Tariffs ,
Trade Agreements ,
Trade Policy ,
Trade Relations ,
Trans-Pacific Partnership ,
UK ,
UK Brexit ,
WTO
The object of this Alert is to highlight some practical implications of Brexit for the supply of pharmaceutical products and medical devices in the European Union (EU) and related action items which companies should be...more
4/6/2018
/ EU ,
EU Single Market ,
European Economic Area (EEA) ,
European Medicines Agency (EMA) ,
Free Trade Agreements ,
Marketing Authorization Application ,
Medical Devices ,
Pharmaceutical Industry ,
Supply Chain ,
UK ,
UK Brexit
EU and US laws prohibit merging companies from implementing reportable transactions until their deal is cleared or the statutory waiting period has expired. Violations of this principle are colloquially known as “gun-jumping”...more
2/15/2018
/ Antitrust Violations ,
Court of Justice of the European Union (CJEU) ,
Department of Justice (DOJ) ,
EU ,
Federal Trade Commission (FTC) ,
Gun-Jumping ,
Merger Controls ,
Mergers ,
New Guidance ,
Sherman Act ,
Treaty on the Functioning of the European Union (TFEU)